New radiation therapy shows promise for early liver cancer
NCT ID NCT07278102
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 22 times
Summary
This study is looking at how well a treatment called TheraSphere® works for people with early-stage liver cancer. The treatment uses tiny radioactive beads to target and destroy cancer cells from inside the liver. Researchers will track 200 patients in Korea to see how long they live, how the tumors respond, and what side effects occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, Seoul, 03080, South Korea
Conditions
Explore the condition pages connected to this study.